1-4 of 4
Kazuyoshi Yanagihara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A008: Establishment of novel gastric cancer PDX models and cell lines for developing new therapeutics

Takeshi Kuwata, Kazuyoshi Yanagihara
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A008.
https://doi.org/10.1158/1535-7163.TARG-17-A008
Published: 01 January 2018
View article titled, Abstract A008: Establishment of novel gastric cancer PDX models and cell lines for developing new therapeutics
Journal Articles

Abstract A241: Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells.

Wataru Okamoto, Isamu Okamoto, Katsuya Tuchihara, Kazuyoshi Yanagihara, Kazuto Nishio, Kazuhiko Nakagawa
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A241.
https://doi.org/10.1158/1535-7163.TARG-13-A241
Published: 01 November 2013
View article titled, Abstract A241: Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells.
Journal Articles

Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for MET Amplification

Wataru Okamoto, Isamu Okamoto, Tokuzo Arao, Kiyoko Kuwata, Erina Hatashita, Haruka Yamaguchi, Kazuko Sakai, Kazuyoshi Yanagihara, Kazuto Nishio, Kazuhiko Nakagawa
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (7): 1557–1564.
https://doi.org/10.1158/1535-7163.MCT-11-0934
Published: 05 July 2012
View article titled, Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for <em>MET</em> Amplification
Open the PDF for Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for <em>MET</em> Amplification in another window
Includes: Supplementary data
Journal Articles

Identification of c-Src as a Potential Therapeutic Target for Gastric Cancer and of MET Activation as a Cause of Resistance to c-Src Inhibition

Wataru Okamoto, Isamu Okamoto, Takeshi Yoshida, Kunio Okamoto, Ken Takezawa, Erina Hatashita, Yuki Yamada, Kiyoko Kuwata, Tokuzo Arao, Kazuyoshi Yanagihara, Masahiro Fukuoka, Kazuto Nishio, Kazuhiko Nakagawa
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (5): 1188–1197.
https://doi.org/10.1158/1535-7163.MCT-10-0002
Published: 09 May 2010
View article titled, Identification of c-Src as a Potential Therapeutic Target for Gastric Cancer and of MET Activation as a Cause of Resistance to c-Src Inhibition
Open the PDF for Identification of c-Src as a Potential Therapeutic Target for Gastric Cancer and of MET Activation as a Cause of Resistance to c-Src Inhibition in another window
Includes: Supplementary data